• 使用量数据显示利尿剂血管紧张素转换抑制剂供应药物(分别为42%和27%),符合南非降压治疗指南

    Supply data showed that, in line with treatment guidelines, diuretics and angiotensin-converting enzyme inhibitors were the most frequently supplied medicines (42% and 27%, respectively).

    youdao

  • 血压控制药物血管紧张素转化抑制剂(acei)可以降低血压,减少蛋白质尿中的排泄。

    Blood pressure medications. Drugs called angiotensin-converting enzyme inhibitors reduce blood pressure and also reduce the amount of protein released in urine.

    youdao

  • 血管紧张素转化(ace)抑制剂

    Angiotensin-converting enzyme (ACE) inhibitors.

    youdao

  • 一种血管紧张素转换抑制剂

    This drug is an angiotensin converting enzyme inhibitor.

    youdao

  • 目的探讨应用血管紧张素转化抑制剂(acei)治疗血管疾病引起急性肾衰竭高钾血症原因及其应对方法

    OBJECTIVE: To study the reasons for acute renal failure (ARF) and hyperkalemia caused by ACEI which is used for treating cardiovascular disease, and the dealing method.

    youdao

  • 醛固酮抑制剂血管紧张素转换酶抑制剂可辅助阻断RAAS有助于防止小管损失身体保钾,这样可减少口服补钾

    Aldosterone inhibitors and ACE inhibitors help block the RAAS and help prevent potassium loss in the distal tubules. The body conserves potassium, and less oral potassium supplementation is needed.

    youdao

  • 血管紧张转化酶抑制剂治疗高血压心脏衰竭治疗方式。

    ACE inhibitors are a type of medication used to treat high blood pressure and heart failure.

    youdao

  • 目的评价血管紧张素转换抑制剂ACEI卡托普利缺血心肌药理作用

    Objective To evaluate the pharmaceutical effect of angiotensin-converting enzyme inhibitor(ACEI) captopril on ischemic myocardium.

    youdao

  • 用瑞士杆菌生产具有抑制血管紧张转换ACE活性发酵其中分离血管紧张素转换酶抑制剂ACEI)。

    To produce fermented milk that can inhibit the activity of angiotensin converting enzyme(ACE), then the angiotensin converting enzyme inhibitor(ACEI) can be purified from the fermented milk.

    youdao

  • 目的研究血管紧张转换抑制剂(acei)血管紧张素受体拮抗剂(arb)2糖尿病肾病患者肾功能保护作用

    Objective to investigate the protective effect of angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor antagonist (ARB) on renal function of type 2 diabetic nephropathy patients.

    youdao

  • 报道种用反相hplc技术简便、有效地研究血管紧张素转化抑制剂体外抑制动力学方法

    A simple reversed_phase HPLC method for the study of in_vitro inhibition kinetics of angiotensin_converting enzyme inhibitors is described.

    youdao

  • 目的研究阿司匹林血管紧张转换抑制剂(acei)联合使用急性心肌梗塞(ami)患者病死率的影响

    Objective: This study was to evaluate the clinical effects of angiotensin converting enzyme inhibitors (ACEI) with aspirin treatment for acute myocardial infarction (AMI).

    youdao

  • 近年来,许多学者血管紧张素转化抑制剂抑制率测定方法开展了大量研究工作

    A lot of research work has been carried out about the analytical method for inhibitory activity of the angiotensin-converting enzyme in recent years.

    youdao

  • 血管紧张素转化抑制剂血管紧张受体拮抗剂联合用药治疗CKD是否应用要好?

    Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination therapy Better Than Monotherapy and Safe in Patients With CKD?

    youdao

  • 目的了解慢性衰(CRF)患者应用转换抑制剂(acei)后血浆心(ANF)素-血管紧张素系统(RAS)激相互影响

    Objective to study the interaction of renin-angiotensin system (RAS) and atrial natriuretic factor (ANF) under acute angiotensin converting enzyme inhibitors (ACEI) in chronic renal failure (CRF).

    youdao

  • 目的观察血管紧张素转换抑制剂苯那普利减轻幼龄肾病大鼠蛋白尿作用

    Objective To observe the effect of benazepril, an angiotensin converting enzyme inhibitor (ACEI) , on reducing proteinuria in a nephrotic young rat model of with massive proteinuria.

    youdao

  • 目的观察血管紧张素转换酶抑制剂(acei)减少急性心肌梗塞(ami)患者心肌缺血及其相关事件影响

    AIM to study the effect of angiotensin converting inhibitor (ACEI) reduces myocardial ischemia and related events after acute myocardial infarction (AMI).

    youdao

  • 第二血管紧张素转化抑制剂依那普利药理作用临床应用作一简要综述。

    The purest of the writing is to summarize the pharmacal effect and clinical practice of the second angiotensin - converting enzyme inhibitors enalapril.

    youdao

  • 抑制50%血管紧张素转换活性所需抑制剂浓度定义IC 50。

    The concentration of ACE inhibitors needed to inhibit 50% of ACE activity was defined as the IC50 value.

    youdao

  • 而那些降低房颤发病有胸痛(OR 0.35),非白种人(OR 0.61),糖尿病(OR 0.67)血管紧张素转换酶抑制剂应用(OR 0.63)。

    Factors that significantly reduced AF onset included chest pain (or 0.35), non-Caucasian race (or 0.61), diabetes (or 0.67) and ace inhibitor use (or 0.63).

    youdao

  • 结论应用血管紧张素转换抑制剂(acei)治疗原发性高血压,宜首选培哚普利

    Conclusion it is suggested that perindopril should be the first choice when angiotensin converting enzyme inhibitor (ACEI) is taken into account for the therapy of primary hypertension.

    youdao

  • 目的探讨凋亡基因大鼠心肌梗死表达血管紧张素转化酶抑制剂(acei)干预作用

    Objective to investigate the expression of apoptosis - related genes in rats with myocardial infarction and effects of ACEI.

    youdao

  • 目的探讨急性心功能不全状态下动脉血流血管床血流灌注改变血管紧张转换酶抑制剂影响

    Objective to investigate the changes and the effects of captopril on the renal blood flow and microvascular perfusion in dogs with acute cardiac insufficiency.

    youdao

  • 血管紧张转换抑制剂(acei)治疗冠心病各型动脉内皮依赖性舒张功能治疗前比较均有显著性改善,其中DD基因型改善最为明显。

    After the therapy with angiotensin converting enzyme inhibitor (ACEI), the endothelium-dependent vasodilation function was improved in the coronary groups and especially for the DD group.

    youdao

  • 血管紧张素转换抑制剂治疗血管疾病特别是高血压心力衰竭重要药物

    Angiotensin - Converting enzyme inhibitors are important drugs for cardiovascular diseases, especially hypertension and heart failure.

    youdao

  • 血管紧张素转换酶抑制剂通过舒张血管减少容量而降血压。

    They reduce blood pressure through vasodilation and reduction of blood volume.

    youdao

  • 不到15的时间内,血管紧张转换(ace)抑制剂成为治疗高血压病慢性心力衰竭重要一类药物之一。

    In less than 15 years, angiotensin converting enzyme (ACE) inhibitors have become one of the most important classes of drugs for treating hypertension and chronic heart failure.

    youdao

  • 目的阐述血管紧张素转换抑制剂研究进展临床应用历程,评价疗效安全性

    OBJECTIVE:To summarize the aspect of clinical usage and research progress in angiotensin converting enzyme inhibitors(ACEI)and evaluate its clinical efficacy and safety.

    youdao

  • 我们比较血管紧张素转换抑制剂雷米普利血管紧张素受体拮抗剂替米沙坦以及联合血管疾病高位糖尿病患者的作用。

    We compared the ACE inhibitor ramipril, the ARB telmisartan, and the combination of the two drugs in patients with vascular disease or high-risk diabetes.

    youdao

  • 肾脏疾病曾经是90%硬皮病相关死亡致死因直到上世纪八十年代被称为血管紧张素转化(ace)抑制剂降压药物问世

    Kidney disease used to cause 90 percent of scleroderma-related deaths until the advent of a class of blood pressure drugs called angiotensin-converting enzyme, or ACE, inhibitors in the 1980s.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定